SEHK:2877Pharmaceuticals
China Shineway Pharmaceutical Group (SEHK:2877) Net Margin Expansion Tests Bearish Earnings Narratives
China Shineway Pharmaceutical Group (SEHK:2877) has released its FY 2025 numbers with first half revenue of about C¥1.7b and basic EPS of C¥0.81, setting the tone against a trailing twelve month EPS of C¥1.26 on revenue of roughly C¥3.1b. Over recent periods the company has seen half yearly revenue move between C¥1.7b and C¥2.1b, while basic EPS has ranged from C¥0.28 to C¥0.83, giving investors a clear sense of how current results sit within its recent track record. With earnings growth over...